Pneumococcal Polysaccharide Abrogates Conjugate-Induced Germinal Center Reaction and Depletes Antibody Secreting Cell Pool, Causing Hyporesponsiveness

Novel vaccine development strategies for inducing mucosal immunity

(2012) Yoshiko Fukuyama et al.   Expert Review of Vaccines

The fundamental link between pneumococcal carriage and disease

(2012) Birgit Simell et al.   Expert Review of Vaccines

Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses

(2012) Paul V. Licciardi et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The Adjuvant LT-K63 Can Restore Delayed Maturation of Follicular Dendritic Cells and Poor Persistence of Both Protein- and Polysaccharide-Specific Antibody-Secreting Cells in Neonatal Mice

(2012) S. P. Bjarnarson et al.   JOURNAL OF IMMUNOLOGY

Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells

(2012) Elizabeth A. Clutterbuck et al.   JOURNAL OF INFECTIOUS DISEASES

Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines

(2011) Jan Poolman et al.   Expert Review of Vaccines

Marginal Zone B Cells Regulate Antigen Capture by Marginal Zone Macrophages

(2011) Y. You et al.   JOURNAL OF IMMUNOLOGY

Hyporesponsiveness Following Booster Immunization With Bacterial Polysaccharides Is Caused by Apoptosis of Memory B Cells

(2011) Siggeir F. Brynjolfsson et al.   JOURNAL OF INFECTIOUS DISEASES

Lower Immunoglobulin G Antibody Responses to Pneumococcal Conjugate Vaccination at the Age of 2 Years after Previous Nasopharyngeal Carriage of Streptococcus pneumoniae

(2011) Gerwin D. Rodenburg et al.   JOURNAL OF PEDIATRICS

The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule

(2011) Martin O. Ota et al.   VACCINE

Increased Risk of Hospitalization for Acute Lower Respiratory Tract Infection among Australian Indigenous Infants 5–23 Months of Age Following Pneumococcal Vaccination: A Cohort Study

(2010) Kerry‐Ann F. O’Grady et al.   CLINICAL INFECTIOUS DISEASES

Nasopharyngeal Carriage ofStreptococcus pneumoniaeShortly before Vaccination with a Pneumococcal Conjugate Vaccine Causes Serotype‐Specific Hyporesponsiveness in Early Infancy

(2010) Ron Dagan et al.   JOURNAL OF INFECTIOUS DISEASES

Serotype-Specific Hyporesponsiveness to Pneumococcal Conjugate Vaccine in Infants Carrying Pneumococcus at the Time of Vaccination

(2010) Merja Väkeväinen et al.   JOURNAL OF PEDIATRICS

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy

(2010) F.M. Russell et al.   VACCINE

Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial

(2010) F.M. Russell et al.   VACCINE

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age

(2010) F.M. Russell et al.   VACCINE

Maternal Antibodies to Pneumolysin but Not to Pneumococcal Surface Protein A Delay Early Pneumococcal Carriage in High-Risk Papua New Guinean Infants

(2009) J. P. Francis et al.   Clinical and Vaccine Immunology

Persistence of Streptococcus pneumoniae urinary antigen excretion after pneumococcal pneumonia

(2008) F. Andreo et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II-dependent pathway for antigen presentation

(2008) Christopher D. Velez et al.   IMMUNOLOGY

Serotype-Specific Immune Unresponsiveness to Pneumococcal Conjugate Vaccine following Invasive Pneumococcal Disease

(2008) R. Borrow et al.   INFECTION AND IMMUNITY